Global HPV Decontamination Systems Market to Exhibit 6.7% CAGR during 2016-2024

Posted by John Warner
6
May 9, 2016
187 Views
Image

HPV, better known as hydrogen peroxide vapour is widely recognized as a bio-contamination agent owing to its broad biological efficacy. It can deactivate microorganisms effectively compared to other conventional decontamination methods such as the usage of formaldehyde. HPV has been tested on various classes of microorganisms and displays excellent material compatibility. HPV decontamination systems work at room temperature with relative humidity. Unlike traditional systems, HPV decontamination systems do not require significantly reduced humidity. The global HPV decontamination systems market is estimated to expand at a CAGR of 6.7% during the period between 2016 and 2024. The overall market was worth US$122.75 mn in 2015 and is projected to reach a valuation of US$220.05 mn by 2024.


Growing Prevalence of Hospital-Acquired Infections to Drive Global HPV Decontamination Systems Market


The growing prevalence of hospital-acquired infections has boosted the growth of the global HPV decontamination systems market. HPV is widely used across hospitals for the complete disinfection of rooms that are used for patient care. Through the process of micro-condensation, HPV decontamination systems eliminate pathogens from an inert environment. The micro-condensation process creates the condition for biological inactivation that kills pathogens. International regulatory bodies stress on sterile testing and aseptic processing. This has fuelled the demand for HPV decontamination systems. Cost effectiveness with minimum downtime to business operations of HPV decontamination systems has further augmented the growth of the market.


Isolators Application Segment to Expand at 7.9% CAGR during 2016-2024


On the basis of applications, the global HPV decontamination systems market has been categorized into isolators, incubators, rooms/ facilities, and autoclave/ cage washer. The demand for HPV decontamination systems is significantly high for laboratory-scale incubators owing to various research activities and accidental spillage. The incubators segment generated revenue worth US$39.81 mn in 2015 that accounted for 30% of the overall revenue generated in that year. During the period between 2016 and 2024, the isolators application segment is estimated to expand at a CAGR of 7.9%. The rapid growth of this segment can be attributed to the usage of barrier technology to minimize the risk of contamination.


Europe Dominates Global HPV Decontamination Systems Market


The global HPV decontamination systems market has been segmented into five key regions: North America, Europe, the Middle East and Africa, Latin America, and Asia Pacific. Due to extensive research and development activities and robust healthcare infrastructure in North America and Europe, there is significant demand for HPV decontamination systems. Europe dominates the overall market due to the major infection outbreaks such as Ebola. In Asia Pacific, the fast growth of research facilities and the growing prevalence of hospital-acquired infections are expected to propel the growth of the HPV decontamination systems market in the region.


Key Players in Global Decontamination Systems Market


Some of the key players in the global HPV decontamination systems market are Steris Corporation, Bioquell plc, Getinge Group, Fedegari Autoclavi SpA, Panasonic Biomedical Sales Europe BV, TOMI Environmental Solutions Inc., Sterilucent Inc., SKAN AG, Howorth Air Technology, MBRAUN, and Labotal Scientific Equipment (1997) Ltd.


A complete brochure for this research is available for download.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10163


Comments
avatar
Please sign in to add comment.